Larimar Therapeutics Inc — Cash Flow (NASDAQ:LRMR) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 42.2 M42.1 M27.57 M33.46 M70.8 M 136.64 M Cash from investing activities 17.09 M24.17 M90.96 M33.35 M85.39 M 10.61 M Cash from financing activities 93.59 M19.89 M75.26 M30 K161.88 M — Free cash flow 42.14 M41.77 M27.47 M33.3 M70.28 M 136.55 M

Nouvelles

L’action Larimar Therapeutics chute de 8% sur une offre rehaussée de 100 millions de dollars

Larimar Therapeutics stock falls 8% on upsized $100 million offering

Larimar Therapeutics fixe le prix d’une offre d’actions de 100 millions $ à 5$ par action

Larimar Therapeutics prices $100M stock offering at $5 per share

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

Larimar Therapeutics lance une offre publique d’actions de 75 millions $

Larimar Therapeutics launches $75M public stock offering

Netflix and Palantir among market cap stock movers on Wednesday

Oracle and Netflix among market cap stock movers on Wednesday

Laminar Therapeutics Stock Is Popping Today: What's Going On? - Larimar Therapeutics (NASDAQ:LRMR)

Le titre Larimar Therapeutics s’envole après l’obtention du statut de percée de la FDA

Larimar Therapeutics stock surges on FDA breakthrough status